Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest reportWe are striving to make a valuable contribution to the areas where we operate, alongside our global contribution to supporting the production of low carbon nuclear energy. We wanted to know how we were doing and asked an independent researcher to find out, starting with our UK site, Urenco Capenhurst.
The socioeconomic impact assessment, produced by Oxford Economics, revealed:
Mike Peers, Chief Nuclear Officer, Urenco Capenhurst
Chris Lloyd, Group Chief Nuclear Officer
Laura Johnson, Deputy Communications Manager